Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Net Cash Flow (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Net Cash Flow for 4 consecutive years, with $153.8 million as the latest value for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 151.65% year-over-year to $153.8 million; the TTM value through Dec 2025 reached $72.1 million, up 168.15%, while the annual FY2025 figure was $72.1 million, 168.15% up from the prior year.
  • Net Cash Flow was $153.8 million for Q4 2025 at Day One Biopharmaceuticals, up from $7.7 million in the prior quarter.
  • The five-year high for Net Cash Flow was $183.1 million in Q3 2024, with the low at -$297.8 million in Q4 2024.
  • Historically, Net Cash Flow has averaged -$5.5 million across 4 years, with a median of -$4.1 million in 2023.
  • Biggest YoY gain for Net Cash Flow was 252.43% in 2024; the steepest drop was 2764.81% in 2024.
  • Over 4 years, Net Cash Flow stood at -$35.6 million in 2022, then soared by 70.8% to -$10.4 million in 2023, then tumbled by 2764.81% to -$297.8 million in 2024, then skyrocketed by 151.65% to $153.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $153.8 million in Q4 2025, $7.7 million in Q3 2025, and $2.3 million in Q2 2025.